U.S., Texas recommend ‘pause’ for J&J vaccine over blood clot reports

WASHINGTON, DC — The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson Covid-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts.

More than 6.8 million doses of the J&J vaccine have been administered in the U.S. U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers were expected to follow.

Following the federal move, the Texas Department of State Health Services issued a statement Tuesday asking vaccine providers in the state to also pause all administration of the J&J vaccine.

“Right now, these adverse events appear to be extremely rare and are being further evaluated to ensure vaccine safety. People who have received the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their health care provider,” DSHS said.

None of the cases of blood clots reported at this time have occurred in Texas.

The post U.S., Texas recommend ‘pause’ for J&J vaccine over blood clot reports appeared first on KVIA.

Texas News